{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:10:22Z","timestamp":1783901422493,"version":"3.55.0"},"reference-count":22,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective<\/jats:bold>\n                    : Neonatal sepsis is a leading cause of morbidity and mortality in newborns. Timely and accurate diagnosis remains a challenge due to the nonspecific clinical signs and the limited sensitivity and specificity of conventional biomarkers such as C-reactive protein (CRP), procalcitonin (PCT), and white blood cell (WBC) count. Presepsin, a soluble CD14 subtype, has been proposed as a promising early marker of bacterial infection.\n                  <\/jats:p>\n                  <jats:p>This study aimed to assess the diagnostic value of serum presepsin in comparison with traditional inflammatory markers in neonates with suspected sepsis.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods<\/jats:bold>\n                    : In a prospective observational study conducted at a single tertiary care center, 18 neonates with clinical signs of sepsis were evaluated. The patients were divided into culture-proven (n=7) and culture-unproven (n=11) sepsis groups. Presepsin levels were measured using a chemiluminescent assay and compared to CRP, PCT, and WBC counts.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : The median presepsin levels were higher in culture-proven cases (740 ng\/L vs. 393 ng\/L), but without statistical significance. Similar trends were observed for CRP and PCT, while WBC counts showed no diagnostic value.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : Although presepsin demonstrated potential as an early biomarker, its diagnostic performance in this small cohort was inconclusive. Combined use of presepsin with conventional markers and clinical evaluation may improve early sepsis diagnosis in neonates.\n                  <\/jats:p>","DOI":"10.2478\/prilozi-2026-0009","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:07:49Z","timestamp":1774080469000},"page":"85-91","source":"Crossref","is-referenced-by-count":0,"title":["Presepsin in Neonatal Sepsis: A Single-Center Evaluation in Comparison to Conventional Markers"],"prefix":"10.2478","volume":"47","author":[{"given":"Mojca","family":"Kav\u010di\u010d","sequence":"first","affiliation":[{"name":"Department of Neonatology, Division of Pediatrics , University Medical Center Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petja","family":"Fister","sequence":"additional","affiliation":[{"name":"Department for Intensive Care, Division of Pediatrics , University Medical Center Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta Soltirovska","family":"\u0160alamon","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Division of Pediatrics , University Medical Center Ljubljana , Ljubljana , Slovenia"},{"name":"University of Ljubljana , Faculty of Medicine , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u0161ko","family":"Osredkar","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Biochemistry , University Medical Center Ljubljana , Ljubljana , Slovenia"},{"name":"University of Ljubljana , Faculty of Pharmacy , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darja Paro","family":"Panjan","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Division of Pediatrics , University Medical Center Ljubljana , Ljubljana , Slovenia"},{"name":"University of Ljubljana , Faculty of Medicine , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"2026071216021805676_j_prilozi-2026-0009_ref_001","doi-asserted-by":"crossref","unstructured":"Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018 Mar;6(3):223\u201330.","DOI":"10.1016\/S2213-2600(18)30063-8"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_002","doi-asserted-by":"crossref","unstructured":"Maddaloni C, De Rose DU, Santisi A, Martini L, Caoci S, Bersani I, et al. The Emerging Role of Presepsin (P-SEP) in the Diagnosis of Sepsis in the Critically Ill Infant: A Literature Review. Int J Mol Sci. 2021 Nov 10;22(22):12154.","DOI":"10.3390\/ijms222212154"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_003","unstructured":"Milton R, Gillespie D, Dyer C, Taiyari K, Carvalho MJ, Thomson K, et al. Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study. Lancet Glob Health. 2022 May 1;10(5):e661\u201372."},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_004","doi-asserted-by":"crossref","unstructured":"Kosmeri C, Giapros V, Serbis A, Baltogianni M. Application of Advanced Molecular Methods to Study Early-Onset Neonatal Sepsis. Int J Mol Sci. 2024 Feb 13;25(4):2258.","DOI":"10.3390\/ijms25042258"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_005","doi-asserted-by":"crossref","unstructured":"Murthy S, Godinho MA, Guddattu V, Lewis LES, Nair NS. Risk factors of neonatal sepsis in India: A systematic review and meta-analysis. PLoS ONE. 2019 Apr 25;14(4):e0215683.","DOI":"10.1371\/journal.pone.0215683"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_006","doi-asserted-by":"crossref","unstructured":"Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed. 2004 May;89(3):F229-235.","DOI":"10.1136\/adc.2002.023838"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_007","doi-asserted-by":"crossref","unstructured":"Bellos I, Fitrou G, Pergialiotis V, Thomakos N, Perrea DN, Daskalakis G. The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis. Eur J Pediatr. 2018 May;177(5):625\u201332.","DOI":"10.1007\/s00431-018-3114-1"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_008","doi-asserted-by":"crossref","unstructured":"Sourour W, Sanchez V, Sourour M, Burdine J, Lien ER, Nguyen D, et al. The Association between Prolonged Antibiotic Use in Culture Negative Infants and Length of Hospital Stay and Total Hospital Costs. Am J Perinatol. 2023 Apr;40(5):525\u201331.","DOI":"10.1055\/s-0041-1729560"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_009","doi-asserted-by":"crossref","unstructured":"Catassi G, Mateo SG, Occhionero AS, Esposito C, Giorgio V, Aloi M, et al. The importance of gut microbiome in the perinatal period. Eur J Pediatr. 2024;183(12):5085\u2013101.","DOI":"10.1007\/s00431-024-05795-x"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_010","doi-asserted-by":"crossref","unstructured":"Pammi M, Flores A, Versalovic J, Leeflang MM. Molecular assays for the diagnosis of sepsis in neonates. Cochrane Database Syst Rev. 2017 Feb 25;2017(2):CD011926.","DOI":"10.1002\/14651858.CD011926.pub2"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_011","doi-asserted-by":"crossref","unstructured":"Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis. Clin Infect Dis. 2004 Jul 15;39(2):206\u201317.","DOI":"10.1086\/421997"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_012","doi-asserted-by":"crossref","unstructured":"Fleiss N, Shabanova V, Murray TS, Gallagher PG, Bizzarro MJ. The diagnostic utility of obtaining two blood cultures for the diagnosis of early onset sepsis in neonates. J Perinatol. 2024 May;44(5):745\u20137.","DOI":"10.1038\/s41372-024-01914-6"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_013","doi-asserted-by":"crossref","unstructured":"Ruan L, Chen GY, Liu Z, Zhao Y, Xu GY, Li SF, et al. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Crit Care Lond Engl. 2018 Nov 21;22(1):316.","DOI":"10.1186\/s13054-018-2236-1"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_014","doi-asserted-by":"crossref","unstructured":"Pietrasanta C, Ronchi A, Vener C, Poggi C, Ballerini C, Testa L, et al. Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial. Antibiot Basel Switz. 2021 May 14;10(5):580.","DOI":"10.3390\/antibiotics10050580"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_015","doi-asserted-by":"crossref","unstructured":"Botondi V, D\u2019Adamo E, Plebani M, Trubiani O, Perrotta M, Di Ricco L, et al. Perinatal presepsin assessment: a new sepsis diagnostic tool? Clin Chem Lab Med. 2022 Jul 26;60(8):1136\u201344.","DOI":"10.1515\/cclm-2022-0277"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_016","doi-asserted-by":"crossref","unstructured":"Hayes R, Hartnett J, Semova G, Murray C, Murphy K, Carroll L, et al. Correction: Neonatal sepsis definitions from randomised clinical trials. Pediatr Res. 2024 Dec;96(7):1882.","DOI":"10.1038\/s41390-024-03416-9"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_017","doi-asserted-by":"crossref","unstructured":"Rossum A van, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004 Oct 1;4(10):620\u201330.","DOI":"10.1016\/S1473-3099(04)01146-6"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_018","doi-asserted-by":"crossref","unstructured":"Weitkamp JH, Aschner JL. Diagnostic Use of C-Reactive Protein (CRP) in Assessment of Neonatal Sepsis. NeoReviews. 2005 Nov 1; 6(11): e508\u201315.","DOI":"10.1542\/neo.6-11-e508"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_019","doi-asserted-by":"crossref","unstructured":"Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012 Jan 1;18(6):891\u20137.","DOI":"10.1007\/s10156-012-0435-2"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_020","doi-asserted-by":"crossref","unstructured":"Poggi C, Lucenteforte E, Petri D, De Masi S, Dani C. Presepsin for the Diagnosis of Neonatal Early-Onset Sepsis: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022 Aug 1;176(8):750\u20138.","DOI":"10.1001\/jamapediatrics.2022.1647"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_021","doi-asserted-by":"crossref","unstructured":"Chenevier-Gobeaux C, Borderie D, Weiss N, Mallet-Coste T, Claessens YE. Presepsin (sCD14-ST), an innate immune response marker in sepsis. Clin Chim Acta Int J Clin Chem. 2015 Oct 23;450:97\u2013103.","DOI":"10.1016\/j.cca.2015.06.026"},{"key":"2026071216021805676_j_prilozi-2026-0009_ref_022","doi-asserted-by":"crossref","unstructured":"Rello J, Alonso-Tarr\u00e9s C. Emerging Technologies for Microbiologic Diagnosis of Sepsis: The Rapid Determination of Resistance to Antimicrobial Agents Should Be the Key. Clin Infect Dis. 2021 Oct 1;73(7):1173\u20135.","DOI":"10.1093\/cid\/ciab355"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2026-0009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:54:20Z","timestamp":1783900460000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2026-0009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,21]]},"published-print":{"date-parts":[[2026,3,1]]}},"alternative-id":["10.2478\/prilozi-2026-0009"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2026-0009","relation":{},"ISSN":["1857-8985"],"issn-type":[{"value":"1857-8985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}